These inform suitability, safe starting dose, and monitoring frequency throughout treatment
These include temporary skin redness, itch, or irritation after topical application, reported in a small percent of users, single-digit percentages in trials
Who should avoid it
Supporting 25% of novel drug approvals* across FDA and EMA Signant Health's technology and services have supported a quarter of all regulatory authorizations for new active substances in their first indications across major global markets
Most users notice improvements in endurance and recovery within 1 to 2 weeks of consistent use
Her journey through healing, brain surgery, and recovery has led her to become a powerful advocate for integrative care, nervous system regulation, and detoxification